GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alligator Bioscience AB (STU:7AL) » Definitions » ROE % Adjusted to Book Value

Alligator Bioscience AB (STU:7AL) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Alligator Bioscience AB ROE % Adjusted to Book Value?

Alligator Bioscience AB's ROE % for the quarter that ended in Mar. 2024 was 0.00%. Alligator Bioscience AB's PB Ratio for the quarter that ended in Mar. 2024 was N/A. Alligator Bioscience AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.


Alligator Bioscience AB ROE % Adjusted to Book Value Historical Data

The historical data trend for Alligator Bioscience AB's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alligator Bioscience AB ROE % Adjusted to Book Value Chart

Alligator Bioscience AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -36.66 -25.03 -17.33

Alligator Bioscience AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -69.76 -167.22 -74.89 -22.34 -

Competitive Comparison of Alligator Bioscience AB's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Alligator Bioscience AB's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alligator Bioscience AB's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alligator Bioscience AB's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Alligator Bioscience AB's ROE % Adjusted to Book Value falls into.



Alligator Bioscience AB ROE % Adjusted to Book Value Calculation

Alligator Bioscience AB's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-485.22% / 28.00
=-17.33%

Alligator Bioscience AB's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alligator Bioscience AB ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Alligator Bioscience AB's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Alligator Bioscience AB (STU:7AL) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Medicon Village, Lund, SWE, 223 81
Alligator Bioscience AB is a research-based biotechnology company that develops immune activating antibody drugs for tumor-directed immunotherapy. It is engaged in the development of immunotherapies for the treatment of cancer Its products are ADC-1013, ATOR-1015, and ATOR-1016.

Alligator Bioscience AB (STU:7AL) Headlines

No Headlines